Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma.

Yulong LiuYansong QiaoMiaoli ZhouJiandong GuoYinsheng LinWanghai LiChao AnChengzhi Li

Published in: Cancer medicine (2022)

Compared to HAIC combined with lenvatinib only, HAIC combined with lenvatinib and sequential ablation was safer and more effective, improving survival outcomes of Ad-HCC patients. A prospective study will be designed validate the retrospective results.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
low dose
prognostic factors
patient reported outcomes
radiation therapy